Page last updated: 2024-10-17

phosphonoacetic acid and Immunoblastic Lymphadenopathy

phosphonoacetic acid has been researched along with Immunoblastic Lymphadenopathy in 1 studies

Phosphonoacetic Acid: A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent.
phosphonoacetic acid : A member of the class of phosphonic acids that is phosphonic acid in which the hydrogen attached to the phosphorous is replaced by a carboxymethyl group.

Immunoblastic Lymphadenopathy: A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walmsley, SL1
Chew, E1
Read, SE1
Vellend, H1
Salit, I1
Rachlis, A1
Fanning, MM1

Other Studies

1 other study available for phosphonoacetic acid and Immunoblastic Lymphadenopathy

ArticleYear
Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet).
    The Journal of infectious diseases, 1988, Volume: 157, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet;

1988